Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Shams, Jalaledin"'
Autor:
Ghazanfari, Tooba a, b, ⁎, Rezaei, Abbas c, Rezaei, Ramazan d, Kariminia, Amina e, Naghizadeh, Mohammad Mehdi f, Soroush, MohammadReza g, Shams, Jalaledin h, i, Faghihzadeh, Soghrat j, k, Hassan, Zuhair Mohammad l
Publikováno v:
In International Immunopharmacology 27 January 2025 146
Autor:
Fallahi, Faramarz a, Askari, Nayere b, c, Jamali, Tahereh c, Parsapour, Sara d, Ghasemi, Hassan e, Shams, Jalaledin f, g, Yaraee, Roya h, Ghazanfari, Zeinab i, Ghazanfari, Tooba c, h, ⁎
Publikováno v:
In International Immunopharmacology 3 January 2025 145
Autor:
Ghazanfari, Tooba, Mostafaie, Ali, Talebi, Farideh, Mahdavi, Mohammad Reza Vaez, Yarmohammadi, Mohammad Ebrahim, Askari, Nayere, Moaiedmohseni, Sakine, Majd, Ali Mohammad Mohseni, Mirsharif, Ensie Sadat, Ghazanfari, Zeinab, Hassan, Zuhair Mohammad, Shams, Jalaledin, Jamali, Davoud, Faghihzadeh, Soghrat
Publikováno v:
In International Immunopharmacology March 2020 80
Autor:
Mirsharif, Ensie Sadat, Shams, Jalaledin, Falahi, Faramarz, Moghadam, Mohamad Reza Sedighi, Majd, Ali Mohamad Mohseni, Dilmaghanian, Razieh, Ghazanfari, Tooba
Publikováno v:
In International Immunopharmacology November 2019 76
Autor:
Heidary, Fatemeh, Ardestani, Sussan K., Ghasemi, Hassan, Javadi, Mohammad Ali, Mahmoudi, Mahmoud, Yaraee, Roya, Shams, Jalaledin, Falahi, Faramarz, Sedighi moghadam, Mohamad Reza, Shariatpanahi, Shamsa, Shakeri, Raheleh, Naghizadeh, Mohammad Mehdi, Ghazanfari, Tooba
Publikováno v:
In International Immunopharmacology November 2019 76
Publikováno v:
Iranian Journal of Neurology
Background Interferon beta-la and -1b have been increasingly used for the treatment of multiple sclerosis (MS). The most frequent systemic adverse effects are flu-like symptoms. Laboratory abnormalities include asymptomatic leukopenia and elevated he
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::5022adea2a60db17ae1c6ff52f76f85a
http://europepmc.org/articles/PMC3829218
http://europepmc.org/articles/PMC3829218
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Iranian Journal of Allergy, Asthma & Immunology; 2018 Supplement, Vol. 17, p284-285, 2p
Autor:
Ghazanfari T; Immunoregulation Research Center, Shahed University, Tehran 3319118651, Iran; Department of Immunology, Shahed University, Tehran, Iran. Electronic address: tghazanfari@yahoo.com., Rezaei A; Immunology Department, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran., Rezaei R; Department of Immunology, Medical Faculty, Shahed University, Tehran, Iran., Kariminia A; School of Medicine, University of Washington, Seattle, WA, USA., Naghizadeh MM; Non Communicable Diseases Research Center, Fasa University of Medical Science, Fasa, Iran., Soroush M; Janbazan Medical and Engineering Research Center (JMERC), Tehran, Iran., Shams J; Hematology-Oncology Unit, Internal Medicine Department, Shahed University, Tehran 3319118651, Iran; Department of Oncology and Hematology, Shahed University, Tehran 3319118651, Iran., Faghihzadeh S; Department of Biostatistics and Social Medicine, Zanjan University of Medical Sciences, Zanjan, Iran; Faculty of Medicine, Zanjan University of Medical Science, Zanjan 4515613191, Iran., Hassan ZM; Department of Immunology, Tarbiat Modares University, Tehran, Iran.
Publikováno v:
International immunopharmacology [Int Immunopharmacol] 2024 Dec 20; Vol. 146, pp. 113851. Date of Electronic Publication: 2024 Dec 20.